Clover Health Investments, Corp. (CLOV)

NASDAQ: CLOV · IEX Real-Time Price · USD
0.833
-0.012 (-1.43%)
At close: Mar 28, 2023, 4:00 PM
0.831
-0.002 (-0.26%)
Pre-market: Mar 29, 2023, 4:46 AM EDT
-1.43%
Market Cap 399.61M
Revenue (ttm) 3.48B
Net Income (ttm) -338.84M
Shares Out 479.55M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,612,403
Open 0.847
Previous Close 0.845
Day's Range 0.826 - 0.855
52-Week Range 0.825 - 3.900
Beta 2.10
Analysts Sell
Price Target 1.69 (+102.81%)
Earnings Date May 8, 2023

About CLOV

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee. [Read more]

Sector Healthcare
Founded 2014
Employees 680
Stock Exchange NASDAQ
Ticker Symbol CLOV
Full Company Profile

Financial Performance

In 2022, CLOV's revenue was $3.48 billion, an increase of 136.19% compared to the previous year's $1.47 billion. Losses were -$338.84 million, -42.35% less than in 2021.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for CLOV stock is "Sell." The 12-month stock price forecast is $1.69, which is an increase of 102.81% from the latest price.

Price Target
$1.69
(102.81% upside)
Analyst Consensus: Sell
Stock Forecasts

News

3 SPACs to Sell Before They Go Bust in 2023

Over the past year, traders have looked for SPACs to sell amid a terrible slump in the sector. But the mood may be changing given the level of destruction across the sector.

Other symbols: HYZNWE
4 days ago - InvestorPlace

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Social Capital Hedosophia Holding Corp. III's Directors and Officers for Breach of Fiduciary Duties – IPOC, CLOV

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of...

5 days ago - Business Wire

Clover Health to Present at Barclays 2023 Global Healthcare Conference on March 14, 2023

FRANKLIN, Tenn., March 07, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving ...

3 weeks ago - GlobeNewsWire

Can Q4 Results Help Save Clover Health (CLOV) Stock?

Clover Health (NASDAQ: CLOV) stock is on the rise Tuesday thanks to the company's earnings report for the fourth quarter of 2022. One of the biggest factors that has investors celebrating is Clover H...

1 month ago - InvestorPlace

Clover Health Reports Fourth Quarter and Full Year 2022 Financial Results

Q4 2022 Insurance MCR of 92.4% and FY 2022 Insurance MCR of 91.8%

1 month ago - GlobeNewsWire

Clover Health to Present at Citi's 2023 Healthcare Conference on March 1, 2023

FRANKLIN, Tenn., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...

1 month ago - GlobeNewsWire

Clover Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

FRANKLIN, Tenn., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ac...

2 months ago - GlobeNewsWire

CLOVER HEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating Clover Health Investments Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Clover Health Investments Corp. (NASDAQ: CLOV) ...

2 months ago - Business Wire

Clover Health Provides Business Update and Issues Partial Guidance for Full-Year 2023

FRANKLIN, Tenn., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ac...

2 months ago - GlobeNewsWire

Clover Health to Present at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023

FRANKLIN, Tenn., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...

2 months ago - GlobeNewsWire

Clover Health Issues December 2022 Investor Frequently Asked Questions

FRANKLIN, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...

3 months ago - GlobeNewsWire

Dr. Anna Loengard Joins Clover Health Board of Directors

FRANKLIN, Tenn., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...

4 months ago - GlobeNewsWire

6 Penny Stocks to Sell Right Now

Penny stocks are much riskier than your average investment. After all, you don't typically have a share price below $5 without some problems, be it a failing business plan, poor execution by managemen...

Other symbols: ARVLATIPBRDS
4 months ago - InvestorPlace

7 Penny Stocks Smart Investors Shouldn't Touch With a 10-Foot Pole

The explosive stock market rally seen on Nov. 10 may have invited some investors to start thinking this downturn is coming to a close. However, before you make the move from “risk-off” to “risk-on,” t...

4 months ago - InvestorPlace

Down 22.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Clover Health Investments, Corp. (CLOV)

The heavy selling pressure might have exhausted for Clover Health Investments, Corp. (CLOV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement amon...

4 months ago - Zacks Investment Research

Clover Health Investments, Corp. (CLOV) Reports Q3 Loss, Tops Revenue Estimates

Clover Health Investments, Corp. (CLOV) delivered earnings and revenue surprises of 48.39% and 3.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead f...

5 months ago - Zacks Investment Research

7 Stocks Only Suckers Will Own In This Bear Market

This vicious bear market has spared very few firms in 2022. The S&P 500 has slipped more than 23% so far and it increasingly feels that things are getting worse.

Other symbols: CVNAOPENPTONRDFNTDOCZM
5 months ago - InvestorPlace

Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023

FRANKLIN, Tenn., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that for the 2021 measurement year, the ...

6 months ago - GlobeNewsWire

Clover Health to Report Third Quarter 2022 Financial Results on November 7, 2022

FRANKLIN, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...

6 months ago - GlobeNewsWire

Clover Health Debuts New Medicare Advantage Plans for 2023

FRANKLIN, Tenn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or “Clover Health”), a physician enablement company committed to improving health equity fo...

6 months ago - GlobeNewsWire

Is Chamath Palihapitiya Giving Up on Clover Health (CLOV) Stock?

Clover Health (NASDAQ: CLOV) is losing its sponsor and must fly on alone. Chamath Palihapitiya, the “SPAC King” who brought CLOV stock public in early 2021 at about $16 per share (it's now at $1.86),...

6 months ago - InvestorPlace

7 Nasdaq Stocks to Sell Before They Die

As is typical of a bear market, the Nasdaq has led the other major indices lower over the past year. The tech-heavy index is down 28% over the past 12 months compared with a 17% decline in the S&P 500...

Other symbols: AURBYNDCWBRMTTRMULN
6 months ago - InvestorPlace

Clover Health to Present at 2022 Wells Fargo Healthcare Conference on September 7, 2022

FRANKLIN, Tenn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...

7 months ago - GlobeNewsWire

7 Meme Stocks for Investors to Take Seriously in 2022

Considering how markets have been moving so far this year, you might feel that meme stocks are a thing of the past. Once the markets take a bullish turn, though, expect the retail trading frenzy to fe...

Other symbols: AMCCVNAGEORIVNSNAPTA
7 months ago - InvestorPlace

Clover Health (CLOV) Stock Sinks on Leadership Change Announcement

Source: Wirestock Creators / Shutterstock Clover Health (NASDAQ: CLOV) stock is falling on Tuesday after the company announced changes are coming to its leadership team. The big news affecting Clover...

8 months ago - InvestorPlace